NCT03489941View on ClinicalTrials.gov

A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

April 7, 2018

Primary Completion Date

April 29, 2018

Study Completion Date

April 29, 2018

Conditions
Allergic Conjunctivitis
Interventions
DRUG

EM-100

Subjects will receive one drop in one eye only based on the randomization list, one time over the course of the trial.

DRUG

Zaditor®

Subjects will receive one drop in one eye only based on the randomization list, one time over the course of the trial.

DRUG

Vehicle

Subjects will receive one drop in one eye only based on the randomization list, one time over the course of the trial.

Trial Locations (1)

38119

Total Eye Care, PA, Memphis

All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT03489941 - A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle | Biotech Hunter | Biotech Hunter